“Heterologous DNA/MVA Vaccine Protocol Effective in Stimulating Immune Response Against HTLV-1 in Mouse Model”

https://pubmed.ncbi.nlm.nih.gov/38115107

This study suggests that a heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein may be effective in stimulating an immune response against HTLV-1 in a mouse model.